In the final episode of this series, we speak to Katy Cooper, Suzanne Miller and Cathy Philpot from our research team. Radiotherapy research is critically important for the advancement of radiotherapy practice, whether this is in the way we deliver radiotherapy or how we can use it in combination with other treatments such as immunotherapy or chemotherapy.

Katy is part of the Cambridge Clinical Trials Centre at Cambridge University Hospitals NHS Foundation Trust who oversee the planning, running and recording of clinical trials for radiotherapy. Katy's role is key in assessing patients to join clinical trials right through to their follow up and the dissemination of results, ensuring that every patient's contribution is valued and recorded.

Suzanne works for CRUK RadNet Cambridge in a similar role to Katy. She has been pivotal in the planning of applications for funding for large-scale, multi-centre trials within our team.

Cathy works in translational research for radiotherapy breast cancer trials with CRUK RadNet Cambridge. She works closely with patients with breast cancer and has been involved with an exciting new trial looking at drug combinations for patients who may not have been suitable for radiotherapy.